4//SEC Filing
Armanino Andrew J. 4
Accession 0000899243-23-011187
CIK 0001832415other
Filed
Apr 11, 8:00 PM ET
Accepted
Apr 12, 4:15 PM ET
Size
6.4 KB
Accession
0000899243-23-011187
Insider Transaction Report
Form 4
Armanino Andrew J.
Director
Transactions
- Purchase
Common Stock
2023-04-10$0.82/sh+303,030$250,000→ 454,358 total(indirect: By Trust)
Holdings
- 13,334
Common Stock
Footnotes (3)
- [F1]On April 6, 2023, the Issuer entered into a Securities Purchase Agreement with certain investors (the "PIPE Investors") in a private placement offering, pursuant to which the PIPE Investors agreed to purchase shares of Issuer common stock for $0.825 per share. As one of the PIPE Investors, the Reporting Person acquired 303,030 shares of Issuer common stock on April 10, 2023 for $0.825 per share.
- [F2]The Reporting Person no longer has a reportable beneficial interest in 15,000 shares of Issuer common stock owned by his son and included in the Reporting Person's prior ownership report on Form 4.
- [F3]These shares are owned directly by the Andrew J. Armanino III and Denise M. Armanino Family Trust (the "Armanino Trust"), and indirectly by the Reporting Person and his spouse, Denise M. Armanino, as trustees of the Armanino Trust.
Documents
Issuer
Better Therapeutics, Inc.
CIK 0001832415
Entity typeother
Related Parties
1- filerCIK 0001807550
Filing Metadata
- Form type
- 4
- Filed
- Apr 11, 8:00 PM ET
- Accepted
- Apr 12, 4:15 PM ET
- Size
- 6.4 KB